scholarly journals Creating a better patient journey for patients with heart valve disease

2021 ◽  
Author(s):  
Marta Sitges ◽  
Britt Borregaard ◽  
Ruggero De Paulis ◽  
Paul Nolan ◽  
Wil Woan ◽  
...  
Keyword(s):  
Heart Valve ◽  
Care Pathway ◽  
Valve Disease ◽  
Heart Valve Disease ◽  
Patient Journey

One line summary With the rising prevalence of heart valve disease, we need to make improvements along the care pathway so that people can live longer and better lives.

Evaluation of Patients with Heart Valve Disease

2019 ◽  
pp. 9-19
Author(s):  
Jose Zamorano ◽  
Ciro Santoro ◽  
Álvaro Marco del Castillo
Keyword(s):  
Heart Valve ◽  
Valve Disease ◽  
Heart Valve Disease

scholarly journals Inflammatory Regulation of Valvular Remodeling: The Good(?), the Bad, and the Ugly

2011 ◽  
Vol 2011 ◽  
pp. 1-13 ◽  
Author(s):  
Gretchen J. Mahler ◽  
Jonathan T. Butcher
Keyword(s):  
Heart Valve ◽  
Cell Biology ◽  
Heart Valves ◽  
Valve Disease ◽  
Heart Valve Disease ◽  
Inflammatory Signaling ◽  
Current State ◽  
Valve Remodeling ◽  
Inflammatory Regulation ◽  
Key Questions

Heart valve disease is unique in that it affects both the very young and very old, and does not discriminate by financial affluence, social stratus, or global location. Research over the past decade has transformed our understanding of heart valve cell biology, yet still more remains unclear regarding how these cells respond and adapt to their local microenvironment. Recent studies have identified inflammatory signaling at nearly every point in the life cycle of heart valves, yet its role at each stage is unclear. While the vast majority of evidence points to inflammation as mediating pathological valve remodeling and eventual destruction, some studies suggest inflammation may provide key signals guiding transient adaptive remodeling. Though the mechanisms are far from clear, inflammatory signaling may be a previously unrecognized ally in the quest for controlled rapid tissue remodeling, a key requirement for regenerative medicine approaches for heart valve disease. This paper summarizes the current state of knowledge regarding inflammatory mediation of heart valve remodeling and suggests key questions moving forward.

scholarly journals Perioperative Management of Sectio Caesarea Surgery in Patient With Heart Valve Disorders

2021 ◽  
Vol 1 (1) ◽  
pp. 1
Author(s):  
Purwoko Purwoko ◽  
Zidni Afrokhul Athir
Keyword(s):  
Mitral Regurgitation ◽  
Cesarean Section ◽  
Maternal Mortality ◽  
Pulmonary Edema ◽  
Heart Valve ◽  
Mitral Stenosis ◽  
Valve Disease ◽  
Heart Valve Disease ◽  
Normal Limits ◽  
In Pregnancy

<div class="WordSection1"><p>Cardiovascular disease in pregnancy is common range from 1% to 3 and contributes to 10-15% of maternal mortality. Valvular heart disease accounts for about 25% of cases of cardiac complications in pregnancy and important cause of maternal mortality, some of which are mitral stenosis and mitral regurgitation. Cesarean delivery remains the preferred choice, as it reduces the hemodynamic changes that can occur in normal delivery and allows for better monitoring and hemodynamic management. Our paper provide in-depth information regarding the pathophysiology of heart valve disease in pregnant women and an appropriate perianesthesia approach to obtain a good prognosis. We report a case of a 26-year-old pregnant woman, with obstetric status G1P0A0, 36 weeks’ gestation, body weight 61 kg accompanied by severe mitral regurgitation and moderate mitral stenosis. This patient was planned to undergo elective cesarean section. The patient's condition in the perioperative examination was: GCS E4V5M6, other vital signs within normal limits, SpO2 98-99% in supine position. Other physical and laboratory examinations were also within normal limits. The goal of anesthesia during surgery in patients with heart valve disease undergoing cesarean section maintain pulmonary capillary pressure to prevent acute pulmonary edema. In this case, regional anesthesia of epidural anesthesia was chosen because it can reduce systemic vascular resistance and provide better post-cesarean section pain. The patient's hemodynamics perianesthesia tended to be stable without any complications such as pulmonary edema.</p><p> </p><p> </p></div><br clear="all" /> <br /><p> </p>

Deregulation of TNF expression can also cause heart valve disease

Cytokine ◽  
2016 ◽  
Vol 77 ◽  
pp. 248-249 ◽  
Author(s):  
Derek Lacey ◽  
Philippe Bouillet
Keyword(s):  
Heart Valve ◽  
Valve Disease ◽  
Heart Valve Disease

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

The Lancet ◽  
1990 ◽  
Vol 335 (8705) ◽  
pp. 1541-1544 ◽  
Author(s):  
M.A. Khamashta ◽  
R. Cervera ◽  
R.A. Asherson ◽  
G.R.V. Hughes ◽  
D.J. Coltart ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Heart Valve ◽  
Lupus Erythematosus ◽  
Valve Disease ◽  
Heart Valve Disease ◽  
Systemic Lupus

scholarly journals Heart valve disease in general practice: a clinical overview

2015 ◽  
Vol 65 (632) ◽  
pp. e204-e206 ◽  
Author(s):  
Jessica Webb ◽  
Chris Arden ◽  
John B Chambers
Keyword(s):  
General Practice ◽  
Heart Valve ◽  
Valve Disease ◽  
Heart Valve Disease ◽  
Clinical Overview
Sign in / Sign up

Export Citation Format

Share Document